I-Pirfenidone CAS 53179-13-8 Ubumsulwa ≥99.0% IPF

Incazelo emfushane:

Igama Lekhemikhali: I-Pirfenidone

CAS: 53179-13-8

Ubumsulwa: ≥99.0%

Ukubukeka: I-Crystalline Powder Emhlophe Kuya Kuphuzi Ephuzi

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Ukwelashwa kwe-Idiopathic Pulmonary Fibrosis (IPF)

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Nikeza Ngokuhlanzeka Okuphezulu, Ukukhiqiza Kwezentengiso
Igama Lekhemikhali: I-Pirfenidone
CAS: 53179-13-8

Chemical Properties:

Igama Lekhemikhali I-Pirfenidone
Omqondofana I-Perfenidone;I-5-Methyl-1-Phenylpyridine-2 (1H) -enye;PFD;I-S-7701;I-AMR-69
Inombolo ye-CAS 53179-13-8
Inombolo yeCAT I-RF-API108
Isimo Sesitoko Kukhona kusitoki
I-Molecular Formula I-C12H11NO
Isisindo samangqamuzana 185.22
I-Melting Point 96.0 ukuze 97.0℃
Ukuncibilika I-Soluble ku-DMSO
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka I-Crystalline Powder Emhlophe Kuya Kuphuzi Ephuzi
Ukuhlonza IR
Ubumsulwa ≥99.0%
Ukulahlekelwa Ekumisweni ≤0.50%
I-Sulfated Ash ≤0.20%
Ukungcola Okukodwa ≤0.50%
Ukungcola Okuphelele ≤1.0%
Izinsimbi Ezisindayo ≤20ppm
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-API, Idiopathic Pulmonary Fibrosis (IPF)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-Pirfenidone (CAS: 53179-13-8) iseqenjini lemithi ebizwa ngokuthi ama-antifibrotic agents.I-Pirfenidone ibonise umsebenzi ezimeni eziningi ze-fibrotic, okuhlanganisa lezo zamaphaphu, izinso nesibindi.Kuthinta amasosha omzimba wakho futhi kunciphisa inani le-fibrosis (izibazi) emaphashini.I-Pirfenidone ngomunye wemithi emibili egunyazwe e-Canada ukwelapha i-Idiopathic Pulmonary Fibrosis (IPF).I-Pirfenidone iyi-inhibitor yokukhiqizwa kwe-TGF-β kanye nokukhiqizwa kwe-collagen evuselelwe i-TGF-β, inciphisa ukukhiqizwa kwe-TNF-α ne-IL-1β, futhi inezindawo zokulwa ne-fibrotic kanye ne-anti-inflammatory.Yaqala ukugunyazwa eJapane ukuze zelashwe iziguli ezine-idiopathic pulmonary fibrosis ngemva kokuhlolwa komtholampilo, ngaphansi kwegama lokuhweba le-Pirespa nguShionogi, ngo-2008. Yagunyazwa ukusetshenziswa e-European Union ngo-2011, eCanada ngo-2012, futhi e-United States ngo-Okthoba 2014.

Bhala umyalezo wakho lapha futhi usithumelele wona